Health in Armenia 1,288 indicators covering health for Armenia. IndicatorLatest Year10-yr change Rank Most sold brand of cigarettes - taxes as a % of price - total tax 0.4% 2020 up 83.3% 118th Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.0% 2020 — 109th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 down 100.0% 33rd Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 41st Most sold brand of cigarettes - taxes as a % of price - value added 0.2% 2020 up 325.0% 19th Most sold brand of cigarettes - taxes as a % of price - specific 0.3% 2020 up 55.6% 77th Most sold brand of cigarettes - price in US$ at official exchange 1.44 2020 down 3.4% 129th Number healthy diet unaffordable 1.90 million 2024 up 35.7% 74th Import of environmentally sound technologies 361.74 million 2020 up 57.6% 107th Percentage of people living with HIV who know their HIV status 66 2025 up 32.0% 111th Percentage of people living with HIV who know their status receiving 83 2025 up 53.7% 80th Most sold brand of cigarettes - price in PPP$ 4.5 2020 up 31.2% 114th Export of environmentally sound technologies 34.51 million 2020 up 74.9% 108th Pcv3 number unvaccinated 2,085 2023 down 91.4% 114th Infant mortality 446 2024 down 40.2% 12th Gross national income per capita 20,221 2023 up 50.3% 50th Reported number of human rabies deaths 1 2023 — 48th Life expectancy by age and sex 76.6 2019 up 3.9% 33rd Number of non-autochthonous leprosy cases 0 2024 — 47th Prevalence of wasting, weight for height, female 5.0% 2016 down 2.0% 37th Prevalence of wasting, weight for height, male 4.0% 2016 down 28.6% 48th Percentage of all children enrolled in private institutions of 2.96 2024 down 3.3% 62nd Population with basic handwashing facilities at home 90.3% 2022 up 9.3% 20th Human Development Index 0.811 2023 up 5.9% 49th Prevalence of severe wasting, weight for height, female 1.9% 2016 down 17.4% 13th Prevalence of severe wasting, weight for height, male 1.6% 2016 down 44.8% 27th Prevalence of overweight, weight for height, female 12.7% 2016 up 41.1% 2nd Prevalence of overweight, weight for height, male 14.6% 2016 up 9.8% 3rd HPV immunization coverage estimates among primary target cohort (9-14) 47.0% 2025 up 683.3% 93rd Prevalence of underweight, weight for age, female 2.0% 2016 down 61.5% 71st Prevalence of underweight, weight for age, male 3.2% 2016 down 5.9% 68th Prevalence of stunting, height for age, female 7.8% 2016 down 55.2% 70th Prevalence of stunting, height for age, male 10.9% 2016 down 40.4% 67th How many health warnings are approved by the law for cigarette 12 2022 up 140.0% 48th Tuberculosis - new and relapse cases 1,261 2011 down 9.2% 119th Physiotherapists 85 2022 down 19.0% 90th Diarrhea treatment 36.9% 2016 up 48.2% 62nd Pregnant women receiving prenatal care 99.6% 2016 up 7.1% 6th Coverage of the human papillomavirus vaccine 41 2024 — 61st Generalist medical practitioners 1,373 2022 down 11.6% 73rd Percentage of principal display area mandated to be covered by health 50 2022 up 66.7% 80th Average of 13 International Health Regulations core capacity scores 95.34 2017 up 27.1% 22nd New cases: pulmonary smear-negative 553 2012 down 21.1% 95th Estimated number of pregnant women living with HIV needing 100 2025 unchanged 79th Percentage of principal display area mandated to be covered by health 50 2022 up 66.7% 73rd Percentage of principal display area mandated to be covered by health 50 2022 up 66.7% 80th Average death rate due to natural disasters 199.82 2021 up 3,013.2% 2nd Number of full-time equivalent staff in national agency 1 2022 unchanged 109th Total number of notified TB cases 1,342 2014 down 21.1% 117th The number of people with susceptibility test result for rifampicin 209 2021 — 93rd Estimated number of pregnant women living with HIV 84 2025 up 2.4% 40th Specialist medical practitioners 8,306 2022 up 22.1% 52nd New cases: pulmonary smear unknown/not done 0 2012 — 109th Smear-positive tuberculosis treatment-success rate 63.0% 2011 down 30.0% 158th Share of one year olds who received the rotavirus vaccine 94 2024 up 3.3% 15th Insufficiently active 77.72 2016 down 1.8% 113th Percentage of principal display area mandated to be covered by health 50 2022 unchanged 67th The number of people with susceptibility test result for rifampicin 100 2021 — 2nd Contraceptive prevalence, any method 36.7% 2016 up 10.9% 37th Percentage of principal display area mandated to be covered by health 50 2022 unchanged 67th ← Previous Page 19 of 22 Next →